Words To The Wise: Attorneys Analyze FDA’s Case Against Utah Medical
This article was originally published in The Gray Sheet
Executive Summary
An FDA legal official signaled that the agency's recent loss of a device manufacturing compliance case does not mean that the agency will stop going after firms with deficient quality controls - even in cases where there have been no adverse events or failures associated with the firm's products